Conformational Change in Aspartate Aminotransferase on Substrate Binding Induces Strain in the Catalytic Group and Enhances Catalysis*

Hideyuki HayashiDagger , Hiroyuki MizuguchiDagger , Ikuko Miyahara§, Yoshitaka Nakajima§, Ken Hirotsu§, and Hiroyuki KagamiyamaDagger

From the Dagger  Department of Biochemistry, Osaka Medical College, Takatsuki 569-8686 and § Department of Chemistry, Faculty of Science, Osaka City University, Sumiyoshi-ku, Osaka 558-8585, Japan

Received for publication, September 9, 2002, and in revised form, November 25, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Aspartate aminotransferase has been known to undergo a significant conformational change, in which the small domain approaches the large domain, and the residues at the entrance of the active site pack together, on binding of substrates. Accompanying this conformational change is a two-unit increase in the pKa of the pyridoxal 5'-phosphate-Lys258 aldimine, which has been proposed to enhance catalysis. To elucidate how the conformational change is coupled to the shift in the aldimine pKa and how these changes are involved in catalysis, we analyzed structurally and kinetically an enzyme in which Val39 located at both the domain interface and the entrance of the active site was replaced with a bulkier residue, Phe. The V39F mutant enzyme showed a more open conformation, and the aldimine pKa was lowered by 0.7 unit compared with the wild-type enzyme. When Asn194 had been replaced by Ala in advance, the V39F mutation did not decrease the aldimine pKa, showing that the domain rotation controls the aldimine pKa via the Arg386-Asn194-pyridoxal 5'-phosphate linkage system. The maleate-bound V39F enzyme showed the aldimine pKa 0.9 unit lower than that of the maleate-bound wild-type enzyme. However, the positions of maleate, Asn194, and Arg386 were superimposable between the mutant and the wild-type enzymes; therefore, the domain rotation was not the cause of the lowered aldimine pKa value. The maleate-bound V39F enzyme showed an altered side-chain packing pattern in the 37-39 region, and the lack of repulsion between Gly38 carbonyl O and Tyr225 Oeta seemed to be the cause of the reduced pKa value. Kinetic analysis suggested that the repulsion increases the free energy level of the Michaelis complex and promotes the catalytic reaction.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Aspartate aminotransferase (aspartate, 2-oxoglutarate aminotransferase, EC 2.6.1.1; AspAT)1 is a pyridoxal 5'-phosphate (PLP)-dependent enzyme and catalyzes the reversible transfer of the amino group of aspartate to 2-oxoglutarate by the following Ping Pong Bi Bi mechanism (1), in which E·PLP and E·PMP denote the PLP form (see Equation 1) and the pyridoxamine 5'-phosphate (PMP) form (see Equation 2) of the enzyme, respectively.
<UP>aspartate</UP>+<UP>E · PLP ⇄ oxalacetate</UP>+<UP>E · PMP</UP> (Eq. 1)

2-<UP>oxoglutarate</UP>+<UP>E · PMP ⇄ glutamate</UP>+<UP>E · PLP</UP> (Eq. 2)
The homodimeric structures have been solved for cytosolic (2), mitochondrial (3-5), and Escherichia coli (6, 7) enzymes. Each subunit is composed of large and small domains, and the active site containing the PLP-Lys258 aldimine is located between the two domains. The alpha -carboxylate group of the dicarboxylic substrates binds to Arg386 located at the small domain and the omega -carboxylate group to Arg292* located at the large domain. An asterisk indicates that the residue comes from the neighboring subunit. On the basis of structural, steady-state (1), and transient (8, 9) kinetic studies, the reaction mechanism of AspAT has been proposed (10, 11) and refined (9) (see Scheme I).

The PLP-Lys258 aldimine (internal aldimine) of the unliganded AspAT has an imine pKa value of ~6.5, which is strikingly lower than those of the PLP-amine aldimines with protonated pyridine N (~10; see Ref 13). We have shown that the principle factor that decreases the aldimine pKa value of AspAT is the imine-pyridine torsion of the PLP-Lys258 aldimine (as represented by the torsion angle C3-C4-C4'-Nzeta , expressed as chi , in the panel of Scheme I), rather than the historically accepted electrostatic effect of the neighboring positive charges of Arg292* and Arg386. The torsion of the aldimine, the angle of which spans the range from ~35° (protonated aldimine) (2) to ~90° (unprotonated aldimine) (7), causes a decrease of 3 units in the aldimine pKa (14), whereas the positive charges of the arginine residues decreases the pKa by only 0.7 unit (15). The catalytic significance of the aldimine torsion is considered to be that it increases the energy level of the protonated form of the aldimine in the unliganded enzyme, thereby decreasing the free energy gap between the starting state (the unliganded enzyme plus the free substrate) and the transition state leading to the first irreversible step, i.e. the release of the product oxaloacetate (see Scheme I). This decrease in the free energy gap is estimated to be 16 kJ mol-1 and increases the kcat/Km value for amino acid substrates by 103-fold (14).

The intrinsic pKa of the external aldimine, i.e. the aldimine of PLP and the substrate aspartate, has been estimated to be >11 (14). The elevated pKa is considered to be caused by the aldimine being fixed to a near planar conformation (chi  = -25°) (7) and the deprotonated form being destabilized (14). Accordingly, the external aldimine reduces the fraction of the dead end species H+EL=S. The shift from H+EL=S to ELH+=S is favorable for the progress of the 1,3-prototropic shift (ELH+=S right-arrow K in Scheme I), the first rate-determining step of the entire catalytic reaction (16).

In comparison to the case of the external aldimine, less is understood about the mechanism of controlling the aldimine pKa and its role in catalysis in the Michaelis complex, where PLP still forms the aldimine with Lys258 (6). The intrinsic pKa of the aldimine has been estimated to be 8.8, by spectroscopic analysis of the maleate-bound enzyme, and it has been explained that the increase in the pKa is because of the electrostatic effect of the anionic ligand (17, 18). However, taking into account the relatively weak electrostatic effect (0.7 pH unit) of Arg292* and Arg386 on the aldimine pKa value as described above, we must consider other mechanisms for the upward pKa shift in this complex, such as alterations in the torsion angle of the aldimine and the hydrogen bond network surrounding it. Furthermore, although the increase in the aldimine pKa in the Michaelis complex has been claimed to accelerate the transaldimination step (ELH+·S right-arrow ELH+=S in Scheme I) by shifting the equilibrium from EL·SH+ to ELH+·S in the Michaelis complex (10), its exact role in catalysis is obscure, because the transaldimination step is not rate-determining at all in the catalytic reaction (16).

To solve these problems associated with the Michaelis complex, we set out to carry out structural and mechanical analysis of the complex. Upon formation of the Michaelis complex, AspAT undergoes a conformational change (2-7), in which the small domain approaches the large domain. Together with the domain rotation, the side chains of the residues aligned at the entrance of the active site are reorganized and correctly packed to form a lid over the active site. These changes are expected to cause alterations in the conformation of the aldimine and the hydrogen-bonding pattern around the aldimine in the Michaelis complex. Therefore, we have chosen the mutation of Val39 (19), which exists at the interface of the large and small domains, to a more bulky residue Phe, with the anticipation of hampering the domain rotation and side-chain packing. This mutant enzyme was analyzed together with the wild-type enzyme, to explore the effect of the substrate-induced conformational change on the important catalytic groups.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- The medium used for bacterial growth contained 0.5% yeast extract, 1% peptone, and 0.5% NaCl, pH 7.0. All other chemicals were of the highest grade commercially available.

Site-directed Mutagenesis-- The V39F (19) and N194A (18) mutants of pUC19 containing the E. coli AspAT gene (aspC) were prepared as described. The double mutant V39F/N194A was constructed using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The V39F plasmid was used as a template. The primers for mutagenesis used were 5'-CAT GGC TGC TGC CAT GCC CCA ACC GGT ATC-3' and 5'-GAT ACC GGT TGG GGC ATG GCA GCA GCC ATG-3'. The obtained mutant plasmids were expressed as described previously (20).

Spectroscopic Measurements-- Absorption spectra were measured using a Hitachi U-3300 spectrophotometer (Tokyo, Japan) at 298 K. The buffer solution contained 50 mM buffer component(s) and 0.1 M KCl. The buffer components used were MES-NaOH, HEPES-NaOH, and TAPS-NaOH. The concentration of the AspAT subunit in solution was determined spectrophotometrically using the apparent molar extinction coefficient of epsilon app = 4.7 × 104 M-1cm-1 for the PLP form of the enzyme at 280 nm (20). The pKa value of the aldimine N of the PLP-Lys258 Schiff base was calculated by fitting the data as follows in Equation 3.


&egr;<SUB><UP>app</UP></SUB>=&egr;<SUB><UP>E</UP></SUB>+<FR><NU>&egr;<SUB><UP>EH</UP></SUB>−&egr;<SUB><UP>E</UP></SUB></NU><DE>1+10<SUP><UP>pH-p</UP>K<SUB><UP>a</UP></SUB></SUP></DE></FR> (Eq. 3)
Here, epsilon E and epsilon EH represent the molar absorptivity of the basic (EL) and the acidic (ELH+) forms of the PLP form of the enzyme, respectively, at a fixed wavelength.

Crystallization of the Mutant Enzymes-- Crystallization of V39F AspAT was performed by the hanging drop vapor diffusion method. A 5-µl drop containing 40 mg of protein/ml, 10 mM potassium phosphate, pH 7.0, 10 µM PLP, and 0.3 mM NaN3 was added to 5 µl reservoir solution containing 10 mM potassium phosphate, pH 7.0, and 40% saturated ammonium sulfate and was equilibrated against 400 µl of reservoir solution at 293 K. After 2 days, the drop was seeded with a small crystal of the wild-type (WT) AspAT obtained previously. Crystals with a size (about 0.8 × 0.5 × 0.4 mm) suitable for x-ray experiments were grown for 7 days. Crystals of V39F/N194A AspAT were obtained using the same procedure for V39F AspAT except that the reservoir solution contained 45% saturated ammonium sulfate. Crystals of maleate-bound V39F AspAT were obtained by a co-crystallization method, using the same procedure as that for V39F AspAT except that 1 µl of 1 M maleate was mixed with 5 µl of enzyme solution, and a small crystal of V39F AspAT was used for seeding. The diffraction data for V39F AspAT were collected on the BL6A station at the Photon Factory, High Energy Accelerator Research Organization, Tsukuba, Japan using an x-ray beam of wavelength 1.00 Å at 293 K and Fuji imaging plates with a screenless Weissenberg camera for macromolecular crystallography (21). Data collection was performed using two crystals. The diffraction data for V39F/N194A AspAT and maleate-bounded V39F AspAT were collected with a Rigaku R-AXIS IIc image plate detector mounted on a Rigaku RU-200 rotating anode generator operated at 40 kV and 100 mA with monochromatized CuKalpha radiation at room temperature. Each data collection was performed using one crystal. All data were processed and scaled using the programs DENZO and SCALEPACK (22) (see Table I). The diffraction data for V39F and V39F/N194A AspATs showed good isomorphism with those of WT AspAT; therefore, the coordinates of 1ARS (7) were used as the first model for refinement. The crystals of maleate-bounded V39F AspAT were isomorphous with those of WT AspAT and the 2-methylaspartate complex; thus, the coordinates of 1ART (7) were used as the first model for refinement. Simulated annealing and several subsequent rounds of least squares refinement using X-PLOR (23) were carried out. After each round of refinement, the model obtained was refitted to an electron density map using program O (24). The mutated residues and solvent molecules were modeled on the basis of 2Fo - Fc and Fo - Fc electron density maps. The solvent molecules whose thermal factors were above 100.0 Å2 after refinement were removed from the model. The quality of the model for each structure was evaluated using PROCHECK (25). Table I contains a summary of the refinement statistics. The mean positional error of the atoms from the Luzzati plot was 0.32 Å for both V39F and WT AspATs.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Data collection and refinement statistics


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Aldimine pKa Values-- The absorption spectra of the V39F mutant AspAT (V39F) show an absorption maximum at 358 nm in the alkaline pH region and at 430 nm in the acidic pH region (data not shown), which are identical to those of the WT AspAT and correspond to the unprotonated (EL; see Scheme I) and protonated (ELH+; see Scheme I) structures of the PLP-Lys258 aldimine, respectively (13, 17). The pH dependence of the apparent molar absorptivity at 430 nm is shown in Fig. 1. The aldimine pKa value of V39F is obtained by fitting the data to Equation 3 to be 6.1, which is 0.7 unit lower than that of WT (6.8; see Refs. 9 and 27). Because the aldimine pKa value is closely related to the presence of the hydrogen bond between PLP O3' and Asn194 (14, 15), the effect of the V39F mutation was studied on the N194A mutant AspAT (Fig. 1). The aldimine pKa value of the V39F/N194A double mutant AspAT is 8.7, essentially identical to that of the N194A mutant AspAT (pKa = 8.6; see Ref. 18).


View larger version (23K):
[in this window]
[in a new window]
 
Scheme I.  


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   pH dependence of the apparent molar extinction coefficients at 430 nm of AspATs at 298 K in the presence of 50 mM buffer component(s) and 0.1 M KCl. open circle , WT; , V39F; triangle , N194A; diamond , V39F/N194A; black-square, V39F in the presence of a saturating concentration of maleate. The theoretical lines are drawn using Equation 3. The epsilon E value is set to zero, because the unprotonated aldimine has no absorbance over 400 nm (13).

The binding of maleate to WT causes an increase in the 430-nm absorption band with a concomitant decrease in the 360-nm band, reflecting the increase in the aldimine pKa value (17). Similar spectral changes are observed for the binding of maleate to V39F (data not shown). The aldimine pKa value of the maleate-bound V39F (V39F·maleate) is 7.9 (Fig. 1), which is 0.9 unit lower than the value 8.8 (18) of the maleate-bound WT (WT·maleate). The aldimine pKa values of WT and mutant AspATs in the presence and absence of maleate are summarized in Table II, together with the aldimine torsion angle (chi ) obtained from the crystallographic analysis.

                              
View this table:
[in this window]
[in a new window]
 
Table II
pKa and torsion angle of the aldimines
The pKa values of the PLP-Lys258 aldimine are obtained by fitting the 430-nm absorbance at various pH values to Equation 3. The C3-C4-C4'-Nzeta torsion angles are obtained from the crystallographic data.

Structure of V39F-- The structure of V39F is shown in Fig. 2A, in comparison with the structure of WT. Most of the small domain and a part of the large domain are shown. The large domains of the two enzymes are almost superimposable. However, the position of the small domain of V39F deviates from that of WT. The deviations are most pronounced at the N-terminal part (Met5-Pro48)2 of the small domain and the two helices at the C terminus. The remaining part of the small domain, containing the last part of the long helix and the following helix, shows little deviation.


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 2.   a, superimposed structures (parallel stereo view) of WT and V39F around the active site aligned at the main chain Calpha atoms of the large domain (Val49-Asp325). The large domains are colored magenta (WT) and royal blue (V39F). The large domains of the other subunit (seen at the left edge) are colored red (WT) and blue (V39F). The small domains are colored pink (WT) and cyan (V39F). The side chains of Ile37, Val/Phe39, Asn194, PLP-Lys258, Arg386, Asn69*, and Tyr70* are shown, and the carbon atoms are colored magenta (WT) and cyan (V39F). The van der Waals surfaces of Phe39, Ile37, Asn69*, and Tyr70* of V39F are displayed with dots. The Asp42-Val49 main chains are drawn with dashed lines to avoid complexity. This and the following molecular graphics, except in b, are drawn using MOLMOL (26). b, enlarged view (from the re face) of the PLP-Lys258 aldimine, Asn194, and Arg386 of WT (magenta) and V39F (cyan), together with the 2Fo - Fc omit electron density maps, contoured at a 1.0-sigma level. The image was drawn using Swiss PDB Viewer (version 3.7b2).

Val39 is one of the residues that locate at the entrance of the active site (6) (Fig. 2A). In V39F, the space between the Tyr70* and Asn69* side chains cannot accommodate the bulky side chain of Phe39, and the phenyl ring is excluded from the space. The phenyl ring has a direct steric effect on the side chain of Ile37 and pushes it outward from the active site. This displacement causes the movement of the main chain of the N-terminal part of the small domain outward of the active site, providing a more open conformation of V39F as described above (Fig. 2A). Together with the rotation of the small domain induced by the V39F mutation, the side chain of Arg386 is moved by 0.63 Å outward from the active site (see Fig. 2B and Fig. 4A). This movement caused a small shift (0.33 Å) in the position of the side chain of Asn194, which is hydrogen-bonded to the guanidinium group of Arg386. The entire structure of the V39F/N194A double mutant AspAT is essentially identical to that of V39F (data not shown; see PDB 1IX8).

Structure of the Maleate-bound V39F-- As in the case of WT, maleate forms a complex with V39F with its two carboxylate groups bound to Arg292* and Arg386, causing a significant rotation of the small domain (Fig. 3). Although the improper packing of the side chains around Phe39 hampers the complete rotation of the small domain as observed for WT, the difference in the structure around Arg386 is not significant between V39F·maleate and WT·maleate. As a result, the guanidinium groups of Arg386 and Arg292*, maleate, and the side chain of Asn194 of V39F·maleate are closely superimposable to those of WT·maleate (see Fig. 3 and Fig. 4B). A great difference between the two structures is observed in the region of residues 37-39 (Fig. 4B). On maleate binding to WT, Ile37 moves 3.1 Å to cover the active site with a rotation of 120° (Fig. 4, comparison of A and B). This movement drives the carbonyl O of Gly38 to approach Tyr225 Oeta , causing the formation of a weak hydrogen bond (3.6 Å) between the two atoms. In V39F, on the other hand, the presence of the bulky phenyl ring of Phe39 hampers the movement of the side chain of Ile37 (Fig. 4, comparison of A and B). The position and conformation of residues Ile37-Gly38-Phe39 in V39F·maleate remain like those of the unliganded enzymes.


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 3.   Superimposed structures (parallel stereo view) of WT·maleate and V39F·maleate. The large domains are colored gray (WT) and light orange (V39F), and the small domains are light gray (WT) and yellow (V39F). The large domains of the other subunit are colored black (WT) and khaki (V39F). The side chains of the residues Ile37, Val/Phe39, Asn194, PLP-Lys258, Arg386, and Arg292* are shown, and the carbon atoms are colored light gray (wt) and yellow (V39F). The Asp42-Val49 main chains are drawn with dashed lines.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4.   Pairwise comparisons of the active site structures of WT and V39F in unliganded and maleate-bound forms. Structures are aligned at the main chain Calpha atoms of the large domain (Val49-Asp325). a, WT (carbon atoms in white) and V39F (carbon atoms in cyan). b, WT·maleate (carbon atoms in gray) and V39F·maleate (carbon atoms in yellow). Asterisks show the main chain carbonyl O of Gly38.

Reaction of V39F with 2-Methylaspartate-- To determine the effect of the V39F mutation on the first two steps of the catalytic reaction, the substrate binding and the transaldimination, we analyzed the reaction of V39F with the substrate analogue 2-methylaspartate. The spectral transitions are essentially the same as in the case of WT (14), and the results are analyzed in the same way (data not shown). Briefly, a single exponential process of the spectral change is observed, and extrapolation to t = 0 yielded a spectrum apparently different from that of the unliganded enzyme, indicating the presence of an enzyme-substrate complex rapidly formed from the unliganded enzyme and 2-methylaspartate. The observed single exponential spectral transition is considered to reflect the equilibration process between the rapidly formed species and another species. By combining the results and the chemical properties of 2-methylaspartate, which stops the catalytic reaction at the external aldimine (8), we assigned the two species to be the Michaelis complex (MC) and the external aldimine (EA), as shown in Equation 4 (14).


(Eq. 4)
The apparent rate constant for the spectral change (kapp) is fitted to the equation kapp = ([MeAsp]/(Kd + [MeAsp])) k+2 k-2, and the parameters are obtained as follows (the value of WT is in parenthesis, taken from Ref. 14): Kd, 12 ± 4 mM (1.4 ± 0.1 mM); k+2, 27 ± 4 s-1 (200 ± 4 s-1); k-2, 130 ± 5 s-1 (110 ± 4 s-1).

Reaction of V39F with Aspartate and the Kinetic Isotope Effect-- V39F has 2.5-fold reduced kcat values and 5-fold increased Km values for its amino acid substrates, aspartate and glutamate (19). To analyze the effect of the V39F mutation on the elementary steps, we studied the kinetic isotope effect of the substitution of alpha -1H with 2H on the kinetic parameters. The ratio of kcat for aspartate to kcat for [2-2H]aspartate was 4.6 in V39F, compared with the value 2.0 of WT (20). Essentially no kinetic isotope effect was observed for Km (ratio is 1.0) in either enzyme (20) (this study).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Conformation and the Aldimine pKa-- The pKa values of dissociation groups at the active site of enzymes are generally considered to be regulated mainly by the polarity of the microenvironment and the electrostatic effects (including that of hydrogen bonds) of the surrounding residues. In this study on AspAT, we observed that the conformational change in the enzyme protein significantly affects the pKa of the PLP-Lys258 aldimine at the active site. The V39F mutation causes movement of the small domain outward from the active site (Fig. 2A). Together with this domain rotation, Arg386, the small domain residue located near the PLP-Lys258 aldimine, moves away from the aldimine. Contrary to the expectation that the electrostatic effect of the positive charges of Arg386 on the aldimine would be attenuated in V39F, the aldimine pKa of V39F is 0.7 unit lower than that of WT (see Fig. 1 and Table II). If Asn194, which bridges PLP O3' and Arg386, is removed in advance, the V39F mutation does not decrease the aldimine pKa (see Fig. 1 and Table II), although V39F/N194A shows an essentially identical conformation as V39F (comparison of 1IX6 and 1IX8). These results indicate that the effect of the displacement of Arg386 on the V39F mutation is transmitted through Asn194 to the PLP-Lys258 aldimine and affects its pKa. A possible mechanism for the pKa shift is that the torsion angle chi  of PLP-Lys258, which is the main factor controlling the aldimine pKa (14), is altered. However, because the resolution of V39F AspAT is not high (2.2 Å), the change in chi  is not assessed structurally. The modeled structure of V39F AspAT (1IX6) has a chi  value only 10° larger than that of WT AspAT (1ARS); the difference is not significant. However, it should be noted that what determines the internal aldimine pKa value is the chi  value of the protonated PLP aldimine (14). This structure is not obtained under the crystallization conditions used for 1ARS and 1IX6 (pH 7). A model study indicates that the direction of the movement of the residues Arg386 and Asn194 increases the chi  value of the protonated internal aldimine, by pulling the O3' atom to the re face of the aldimine.3 This is consistent with the decreased pKa value of the aldimine.

Maleate Binding and the Conformational Change-- The above discussion shows the importance of the PLP-Asn194-Arg386 linkage system that controls the aldimine pKa. The structure of V39F·maleate shows that Arg292*, Arg386, Asn194, and maleate are almost superimposable on those of WT·maleate. Therefore, the contribution of the PLP-Asn194-Arg386 system to the control of the aldimine pKa is the same between V39F·maleate and WT·maleate. Accordingly, the 0.9-unit decrease in the pKa of V39F·maleate should be ascribed to alterations in the other part of the structure. The most remarkable change is seen for residues 37-39. In V39F·maleate, because of the steric hindrance of the Phe39 side chain, Gly38 carbonyl O does not approach Tyr225 Oeta (Fig. 4B). Assuming that this change between V39F·maleate and WT·maleate is the cause of the lowered aldimine pKa value of V39F·maleate, we can interpret the results as follows. In the unprotonated aldimine, Tyr225 Oeta forms a hydrogen bond with PLP O3' (2.90 Å for 1ARS and 2.86 Å for 1IX6), in which Tyr225 is the hydrogen donor. The lone pair electrons of Tyr225 Oeta are pointed toward the Gly38 main chain. On the other hand, if the aldimine is protonated, the proton is expected to be shared by PLP O3', imine N, and Tyr225 Oeta , and the hydrogen atom of the Tyr225 OH is pointed toward the Gly38 main chain. Therefore, if the Gly38 main chain approaches Tyr225 on the binding of maleate, the lone pair electrons of Gly38 carbonyl O cause repulsion with Tyr225 Oeta in the unprotonated aldimine (EL·SH+; see Fig. 5A), whereas a hydrogen bond is formed between Tyr225 Oeta and Gly38 carbonyl O in the protonated aldimine (ELH+·S; see Fig. 5A). In ELH+·S, the hydrogen bond lifts the Tyr225 side chain and allows rotation of the PLP pyridine ring, reducing the aldimine torsion angle chi  and thereby stabilizing the structure. As a consequence, the approach of Gly38 to Tyr225 on binding of maleate to WT is considered to destabilize EL·SH+ relative to ELH+·S and increases the aldimine pKa in the Michaelis complex. The binding of maleate to V39F will not increase the aldimine pKa as much, because the movement of Gly38 main chain on the maleate binding is restricted.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   a, schematic representation of the proposed structures of ELH+·S and EL·SH+, showing the hydrogen-bonding pattern. Lone pair electrons are expressed by shaded lobes. b, free energy levels of the reaction intermediates in the reaction pathway starting from the PLP form of AspAT and aspartate to the transition state of the 1,3-prototropic shift. Horizontal bars indicate the free-energy levels expressed in kJ·mol-1. The labels attached to the bars are defined as shown in Scheme I. The horizontal coordinate shows the chemical species sorted by the protonation state. Perpendicular to this one is the reaction coordinate. The broken bars are those of V39F. The energy levels of the transition state are adjusted between WT and V39F. The energy levels are calculated based on the data obtained in this study and Ref. 14, corrected for the difference in the pKa value of the amino acid alpha -amino group (10.6 for MeAsp and 9.6 for aspartate). The rate of the 1,3-prototropic shift of WT is estimated to be 3500 s-1, based on the consideration that this step is 16% rate-determining (calculated using the equation (Dkcat - 1)/Dk+3 - 1); see Ref. 28) in the half-reaction.

Effect of V39F Mutation on the Elementary Steps-- For the analysis of the reaction of AspAT with aspartate at high pH, we consider the information shown in Equation 5 below (9), where MC, EA, and K are the Michaelis complex of the PLP form of AspAT and aspartate, the external aldimine, and the ketimine, respectively (for the structures, see Scheme I).


(Eq. 5)
EM·OA is the Michaelis complex of EM and oxalacetate. The study of Goldberg and Kirsch (16) showed that the rate-determining steps in the forward reaction are the 1,3-prototropic shift between the external aldimine and the ketimine (k+3), the ketimine hydrolysis (k+4), and the release of oxalacetate (k+5). Because the forward transaldimination rate (k+2) is considered to be much larger than other rate constants (16), Dkcat is expressed as shown in Equation 6, where k<UP><SUB>+3</SUB><SUP>*</SUP></UP> = [k+2/(k+2 + k-2)]k+3 and L = (k-3k-4 k-3k+5 + k+4k+5)/(k+4 + k-4 k+5).
<SUP><UP>D</UP></SUP>k<SUB><UP>cat</UP></SUB>=(k<SUP><UP>*H</UP></SUP><SUB><UP>+3</UP></SUB>/L+<SUP><UP>D</UP></SUP>k<SUP>*</SUP><SUB><UP>+3</UP></SUB>)/(k<SUP><UP>*H</UP></SUP><SUB><UP>+3</UP></SUB>/L+1) (Eq. 6)
Because k+2 and k-2 are insensitive to isotopic substitution, Dk<UP><SUB>+3</SUB><SUP>*</SUP></UP> is equal to Dk+3. Using the observed Dkcat value of 2.0 for WT (20) and 4.6 for V39F (this study), and the reported value of Dk+3 = 7.3 for the primary kinetic isotope effect of the 1,3-prototropic shift (28), k<UP><SUB>+3</SUB><SUP>*H</SUP></UP>/L is calculated to be 5.3 for WT and 0.75 for V39F. These values indicate that the V39F mutation decreased the k<UP><SUB>+3</SUB><SUP>*H</SUP></UP> (and k<UP><SUB>+3</SUB><SUP>*D</SUP></UP>) value by 7.1-fold. Therefore, using Equation 7 (shown below), the reduction in the kcat value by the V39F mutation is calculated to be 2.0, which roughly coincides with the observed value of 2.5 (19).
<FR><NU>k<SUB><UP>cat,WT</UP> </SUB></NU><DE>k<SUB><UP>cat,V39F</UP></SUB></DE></FR> =<FR><NU>k*<SUB><UP>+3,WT</UP></SUB><UP>/</UP>L+k*<SUB><UP>+3,WT</UP></SUB>/k*<SUB><UP>+3,V39F</UP> </SUB></NU><DE>k*<SUB><UP>+3,WT</UP></SUB>/L+1</DE></FR> (Eq. 7)
Kinetic data for the reaction with 2-MeAsp show that the V39F mutation increases the k-2/k+2 value by 8.8-fold. Using this value and the value k-2/k+2 = 3, obtained from global kinetic analysis of the reaction of AspAT with aspartate and oxalacetate,4 the V39F mutation is calculated to decrease the k+2/(k+2 k-2) value by 6.9-fold. k<UP><SUB>+3</SUB><SUP>*</SUP></UP> = [k+2/(k+2 + k-2)]k+3 is decreased by 7.1-fold by the mutation (see above). Therefore, the V39F mutation mostly affects the equilibrium between the Michaelis complex and the external aldimine (k+2/(k+2 + k-2)), rather than altering the 1,3-prototropic shift (k+3).

Energetic Interpretation of the Acid-Base Chemistry and Kinetic Parameters-- The results of the acid-base chemistry and kinetics of WT and V39F are interpreted in the three-dimensional free energy profile shown in Fig. 5B. In this free energy profile, the energy levels of all the reaction intermediates are arranged two-dimensionally; one coordinate displays the catalytic step, and the other shows the chemical species with different protonation states. The advantage of this expression is that we can understand energetically how the pKa of a dissociation group is involved in catalysis (14). For comparison of the WT- and V39F-catalyzed reactions, the energy level of the transition state is aligned in Fig. 5B.

In the Michaelis complex of WT, EL·SH+ and ELH+·S have similar energy levels (14). On the V39F mutation, the free energy level of EL·SH+ is decreased by 6.9 kJ·mol-1 whereas that of ELH+·S is decreased by only 1.7 kJ·mol-1. The energy level of the external aldimine is unchanged. The obtained free energy diagram can explain 1) the 0.9-unit decrease in the aldimine pKa in the Michaelis complex, 2) the 9-fold equilibrium shift from the external aldimine to the Michaelis complex, and 3) the increase in the free energy gap between the ground state (the rapid-equilibrium mixture of the Michaelis complex and the external aldimine) and the transition state of the 1,3-prototropic shift, which results in the 7-fold decrease in k<UP><SUB>+3</SUB><SUP>*</SUP></UP>. Thus, a change in essentially a single energy level (EL·SH+) accounts for all the changes in the acid-base and kinetic parameters caused by the V39F mutation. This conclusion is consistent with the comparative structures of WT·maleate and V39F·maleate, the model for the Michaelis complex. That is, if the ligand-induced conformational change of residues 37-39 covering the active site and the concomitant approach of Gly38 main chain to Tyr225 is blocked by the V39F mutation, the enzyme is unable to destabilize the species EL·SH+. The reorientation of the PLP ring in the external aldimine lowers the side chain of Tyr225, and Tyr225 Oeta is distant from the carbonyl O of Gly38 (2, 7) (1ART and 1AJS). We consider that the lack of the Gly38-Tyr225 interaction in the external aldimine is the reason why the V39F mutation does not affect the energy levels of the external aldimine species.

Strain in the Michaelis Complex-- Structural and kinetic analyses of the V39F mutant AspAT described as above provide important findings as follows. First, the conformation of AspAT, i.e. the position of the small domain relative to that of the large domain, affects the aldimine pKa value, and the effect of the conformational change on the aldimine is mediated through the PLP-Asn194-Arg386 linkage system. Second, despite the incorporation of the bulky Phe side chain to the domain interface, which causes outward rotation of the small domain, the position and conformation of the bound maleate and the residues that interact with it, i.e. Arg292*, Asn194, and Arg386, are the same as those in the WT·maleate, showing the flexibility of the small domain. Therefore, the lowered aldimine pKa of V39F·maleate as compared with that of WT·maleate is not because of the outward domain rotation but with the reduction in the Gly38-Tyr225 interaction provided by the ligand-induced packing of the residues at the active site. Together with the kinetic analysis of V39F, it was proposed that the Gly38-Tyr225 interaction destabilizes the unprotonated aldimine species in the Michaelis complex (i.e. ground-state destabilization), and contributes to the increase in kcat. The role of the substrate-induced strain shown in this study is in contrast to that of the torsional strain of the PLP-Lys258 aldimine in the unliganded enzyme, which reduces the energy gap between the starting state (unliganded enzyme plus unbound substrate) and the transition state ESDagger by elevating the free energy level of the starting state and contributes to the increase in kcat/Km (14).

    FOOTNOTES

* This work was supported in part by Scientific Research on Priority Areas 13125101 (to H. H. and K. H.) and by Grant-in-aid for Scientific Research 13680697 (to H. H.) from the Japan Society for the Promotion of Science.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and the structure factors (code 1IX6, 1IX7, and 1IX8) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

To whom correspondence should be sent: Dept. of Biochemistry, Osaka Medical College, 2-7 Daigakumachi, Takatsuki 569-8686, Japan. Tel: 81-72-683-1221 (ext. 2645); Fax: 81-72-684-6516; E-mail: med001@ art.osaka-med.ac.jp.

Published, JBC Papers in Press, December 17, 2002, DOI 10.1074/jbc.M209235200

2 The amino acid residues are numbered according to the sequence of pig cytosolic aspartate aminotransferase (12). According to this numbering system, the N-terminal residue is Met-5.

3 H. Hayashi and H. Kagamiyama, unpublished results.

4 H. Hayashi and H. Kagamiyama, unpublished results.

    ABBREVIATIONS

The abbreviations used are: AspAT, aspartate aminotransferase (aspartate, 2-oxoglutarate aminotransferase, EC 2.6.1.1); PLP, pyridoxal 5'-phosphate; PMP, pyridoxamine 5'-phosphate; V39F AspAT, mutant AspAT in which the residue Val39 has been replaced with a phenylalanine residue (other mutant AspATs are expressed in the same way); WT, wild-type; MES, 4-morpholineethanesulfonic acid; TAPS, 3-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}-1-propanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Kiick, D. M., and Cook, P. F. (1983) Biochemistry 22, 375-382[Medline] [Order article via Infotrieve]
2. Rhee, S., Silva, M. M., Hyde, C. C., Rogers, P. H., Metzler, C. M., Metzler, D. E., and Arnone, A. (1997) J. Biol. Chem. 272, 17293-17302[Abstract/Free Full Text]
3. McPhalen, C. A., Vincent, M. G., and Jansonius, J. N. (1992) J. Mol. Biol. 225, 495-517[Medline] [Order article via Infotrieve]
4. Malashkevich, V. N., Toney, M. D., and Jansonius, J. N. (1993) Biochemistry 32, 13451-13462[Medline] [Order article via Infotrieve]
5. Malashkevich, V. N., Strokopytov, B. V., Borisov, V. V., Dauter, Z., Wilson, K. S., and Torchinsky, Y. M. (1995) J. Mol. Biol. 247, 111-124[CrossRef][Medline] [Order article via Infotrieve]
6. Jägar, J., Moser, M., Sauder, U., and Jansonius, J. N. (1994) J. Mol. Biol. 239, 285-305[CrossRef][Medline] [Order article via Infotrieve]
7. Okamoto, A., Higuchi, T., Hirotsu, K., Kuramitsu, S., and Kagamiyama, H. (1994) J. Biochem. 116, 95-107[Abstract]
8. Fasella, P., and Hammes, G. G. (1967) Biochemistry 6, 1798-1804[Medline] [Order article via Infotrieve]
9. Hayashi, H., and Kagamiyama, H. (1997) Biochemistry 36, 13558-13569[CrossRef][Medline] [Order article via Infotrieve]
10. Ivanov, V. I., and Karpeisky, M. Y. (1969) Adv. Enzymol. Relat. Areas Mol. Biol. 32, 21-53[Medline] [Order article via Infotrieve]
11. Kirsch, J. F., Eichele, G., Ford, G. C., Vincent, M. G., Jansonius, J. N., Gehring, H., and Christen, P. (1984) J. Mol. Biol. 174, 497-525[Medline] [Order article via Infotrieve]
12. Ovchinnikov, Yu., Egorov, C. A., Aldanova, N. A., Feigina, M. Yu., Lipkin, V. M., Abdulaev, N. G., Grishin, E. V., Kiselev, A. P., Modyanov, N. N., Braunstein, A. E., Polyanovsky, O. L., and Nosikov, V. V. (1973) FEBS Lett. 29, 31-34[CrossRef][Medline] [Order article via Infotrieve]
13. Kallen, R. G., Korpela, T., Martell, A. E., Matsushima, Y., Metzler, C. M., Metzler, D. E., Morozov, Yu. V., Ralston, I. M., Savin, F. A., Torchinsky, Yu. M., and Ueno, H. (1985) in Transaminases (Christen, P. , and Metzler, D. E., eds) , pp. 37-108, John Wiley & Sons, Inc., New York
14. Hayashi, H., Mizuguchi, H., and Kagamiyama, H. (1998) Biochemistry 37, 15076-15085[CrossRef][Medline] [Order article via Infotrieve]
15. Mizuguchi, H., Hayashi, H., Okada, K., Miyahara, I., Hirotsu, K., and Kagamiyama, H. (2001) Biochemistry 40, 353-360[CrossRef][Medline] [Order article via Infotrieve]
16. Goldberg, J. M., and Kirsch, J. F. (1996) Biochemistry 35, 5280-5291[CrossRef][Medline] [Order article via Infotrieve]
17. Jenkins, W. T., and Sizer, I. W. (1957) J. Am. Chem. Soc. 79, 2655-2656
18. Yano, T., Mizuno, T., and Kagamiyama, H. (1993) Biochemistry 32, 1810-1815[Medline] [Order article via Infotrieve]
19. Hayashi, H., Kuramitsu, S., and Kagamiyama, H. (1991) J. Biochem. 109, 699-704[Abstract]
20. Kuramitsu, S., Hiromi, K., Hayashi, H., Morino, Y., and Kagamiyama, H. (1990) Biochemistry 29, 5469-5476[Medline] [Order article via Infotrieve]
21. Sakabe, N. (1991) Nucl. Instrum. Methods Phys. Res. A303, 448-463
22. Otwinowski, Z. (1989) in Data Collection and Processing, Proceedings of CCP4 Study Weekend (Sawyer, L. , Isaacs, N. , and Bailey, S., eds) , pp. 56-62, S.E.R.C. Daresbury Laboratory, United Kingdom
23. Brunger, A. T., Kuriyan, K., and Karplus, M. (1987) Science 235, 458-461
24. Jones, T. A., Zou, J.-Y., and Kjeldgaard, M. (1991) Acta Crystallogr. Sect. A 47, 110-119[CrossRef][Medline] [Order article via Infotrieve]
25. Lawkowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) J. Appl. Crystallogr. 26, 283-291[CrossRef]
26. Koradi, R., Billeter, M., and Wüthrich, K. (1996) J. Mol. Graphics 14, 51-55[CrossRef][Medline] [Order article via Infotrieve]
27. Gloss, L. M., and Kirsch, J. F. (1995) Biochemistry 34, 3990-3998[Medline] [Order article via Infotrieve]
28. Onuffer, J. J., Ton, B. T., Klement, I., and Kirsch, J. F. (1995) Protein Sci. 4, 1743-1749[Abstract/Free Full Text]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.